Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2026-02-26 @ 4:16 PM
Study NCT ID:
NCT00646659
Status:
TERMINATED
Last Update Posted:
2018-07-09
First Post:
2008-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Head and Neck Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | stage III squamous cell carcinoma of the hypopharynx | View |
| None | stage III squamous cell carcinoma of the larynx | View |
| None | stage III squamous cell carcinoma of the lip and oral … | View |
| None | stage III squamous cell carcinoma of the oropharynx | View |
| None | stage IV squamous cell carcinoma of the hypopharynx | View |
| None | stage IV squamous cell carcinoma of the larynx | View |
| None | stage IV squamous cell carcinoma of the lip and oral … | View |
| None | stage IV squamous cell carcinoma of the oropharynx | View |
| None | untreated metastatic squamous neck cancer with occult primary | View |